@article{3df2d6950bb5455482a8b5b4034bcd4e,
title = "Belangrijke nieuwe informatie over werkzaamheid en veiligheid: Sint- janskruid op de balans van werking en interacties",
abstract = "Recently, two importance articles about St. John's wort (Hypericum perforatum) appeared in the medical literature: a randomised clinical trial comparing St. John's wort with placebo and imipramine and a commentary about interactions between St. John's wort and registered medicines. These publications are discussed in the broader perspective of a benefit-risk assessment.",
keywords = "amitriptyline, anticoagulant agent, anticonvulsive agent, antidepressant agent, antifungal agent, antihistaminic agent, antivirus agent, astemizole, calcium antagonist, carbamazepine, clozapine, corticosteroid, cyclosporin, digoxin, ethinylestradiol, fluoxetine, hyperforin, hypericin, imipramine, immunosuppressive agent, indinavir, neuroleptic agent, phenprocoumon, serotonin uptake inhibitor, tacrolimus, theophylline derivative, tricyclic antidepressant agent, unindexed drug, warfarin, clinical trial, depression, drug efficacy, herbal medicine, human, Hypericum perforatum, major clinical study, mental disease, psychopharmacotherapy, review, risk benefit analysis, treatment outcome",
author = "{De Smet}, P.A.G.M. and D.J. Touw",
year = "2000",
month = mar,
day = "31",
language = "Dutch",
volume = "135",
pages = "455--462",
journal = "Pharmaceutisch Weekblad",
issn = "0031-6911",
publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",
number = "13",
}